R-DHAP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting rituximab, dexamethasone, high dose cytarabine and cisplatin that can be used for the treatment of diffuse large B-cell lymphoma, nodular lymphocyte-predominant Hodgkin lymphoma, and mantle cell lymphoma.

**Synonyms:** - R-DHAP - R-DHAP - R-DHAP - R-DHAP (rituximab-abbs) - R-DHAP (rituximab-arrx) - R-DHAP (rituximab-blit) - R-DHAP (rituximab-pvvr) - R-DHAP (rituximab-rite) - R-DHAP (rituximab-rixa) - R-DHAP (rituximab-rixi) - RDHAP - Rituximab Plus Cisplatin/Cytarabine/Dexamethasone - Rituximab-DHAP - Rituximab-Dexamethasone-High Dose ARA-C-Platinol - Rituximab-Dexamethasone-High Dose Cytarabine-Cisplatin - Rituximab/Dexamethasone/High-dose Ara-C/Platinol